Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Richard C Chou"'
Publikováno v:
JCR: Journal of Clinical Rheumatology.
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 11 (2017)
Amyloid beta (Aβ) is a peptide cleaved from amyloid precursor protein that contributes to the formation of senile plaques in Alzheimer’s disease (AD). The relationship between Aβ and astrocyte proliferation in AD remains controversial. Despite pa
Externí odkaz:
https://doaj.org/article/8e4aec2f86884fd080b9c9c53e7dbcce
Autor:
Stephen J. Rozzo, Alan M. Mendelsohn, Alice B. Gottlieb, Siba P. Raychaudhuri, Proton Rahman, Saima Chohan, Philip J. Mease, Richard C Chou, Michael E. Luggen, Ferran J Garcia Fructuoso
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo evaluate efficacy and safety of the anti-interleukin-23p19 monoclonal antibody tildrakizumab in patients with psoriatic arthritis (PsA).MethodsIn this randomised, double-blind, placebo-controlled, phase IIb study, patients with active Ps
Autor:
Alan M. Mendelsohn, Richard C Chou, Michael E. Luggen, Alice B. Gottlieb, P. J. Mease, Saima Chohan, Ana Maria Orbai, Proton Rahman, Siba P. Raychaudhuri, F. J. García Fructuoso, Stephen J. Rozzo
Publikováno v:
Annals of the Rheumatic Diseases. 79:145-146
Background:Tildrakizumab (TIL), a high-affinity anti–interleukin-23p19 monoclonal antibody, is approved to treat moderate to severe plaque psoriasis and is under investigation for treatment of psoriatic arthritis (PsA).1Objectives:To evaluate effic
Autor:
Saima Chohan, Vibeke Strand, Stephen J. Rozzo, Alan M. Mendelsohn, A. Kavanaugh, P. J. Mease, Richard C Chou
Publikováno v:
Annals of the Rheumatic Diseases. 79:1702-1703
Background:Tildrakizumab (TIL), an anti–interleukin (IL)-23p19 monoclonal antibody, is approved in the US, EU, and Australia for treatment of moderate-to-severe plaque psoriasis.1A randomised, double-blind, placebo-controlled, multiple-dose, phase
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
Acute inflammation is a key feature of innate immunity that initiates clearance and repair in infected or damaged tissues. Alternatively, chronic inflammation is implicated in numerous disease processes. The contribution of neuroinflammation to the p
Autor:
Ferran J Garcia Fructuoso, Kristine E Nograles, Philip J. Mease, Saima Chohan, Richard C Chou, Michael E. Luggen, Alan M. Mendelsohn
Publikováno v:
Oral Presentations.
Background Tildrakizumab (TIL), a high-affinity anti–interleukin-23p19 monoclonal antibody, is approved for moderate-to-severe plaque psoriasis treatment and is under investigation for psoriatic arthritis (PsA). Objectives To evaluate the 24-week e
Autor:
Alan M. Mendelsohn, Rocco Ballerini, Arthur Kavanaugh, Vibeke Strand, Christopher T. Ritchlin, Richard C Chou, Stephen J. Rozzo
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB166
Autor:
Richard C Chou, Michael E. Luggen, Ferran J Garcia Fructuoso, Philip J. Mease, Rocco Ballerini, Alice B. Gottlieb, Saima Chohan, Alan M. Mendelsohn
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB165
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB166